Structural studies on an aminopeptidase inside the endoplasmic reticulum

内质网内氨肽酶的结构研究

基本信息

  • 批准号:
    7530620
  • 负责人:
  • 金额:
    $ 8.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Antigen processing is an integral part of cell-mediated immune surveillance and responses that involve MHC- restriction and T cell recognition. Processed antigenic peptides, when presented on cell surface by MHC molecules to T cells, serve as identity tags to be monitored by our immune system. Thus antigen processing and presentation influence the response of an individual to infectious organisms and has been implicated in the susceptibility to diseases and to the development of autoimmunity. One effective way the immune system eliminates virus-infected or malignant cells is to mount a cytotoxic reaction that result in lysis of target cells. This antiviral mechanism generally involves MHC class I molecules to bind peptides processed from viral proteins synthesized within infected cells, and present those foreign antigenic peptides to cytotoxic T lymphocytes (CTLs), which can eliminate virus-infected self-cells and thus eliminate potential sources of new viral production. Therefore, understanding the mechanisms of antigen processing is critical to fight against various pathogens. For an epitope to be recognized by T cells, foreign antigens need to be cut into short peptides with proper sizes in order to form physical complexes with MHC molecules. The precursors of class I antigenic peptides are generated mainly by proteasomes in the cytosol, and are then transported into the lumen of the endoplasmic reticulum (ER) by transporters associated with antigen processing (TAP). Recently, an aminopeptidase inside the ER, named ERAP1, has been identified to be one missing link that trims peptide precursors and generates the final N-termini of class I-restricted epitopes. Our recent success in expressing and purifying active ERAP1, and obtaining crystals of its C-terminal domain (C-dom) in the preliminary crystallization screens, have brought about the exciting possibility of providing high-resolution structural information for this critical enzyme. In this Small Research Project (R03) application, we propose to purify crystallographic quality and quantity of ERAP1 C-dom and complexes for biochemical characterization and high-resolution crystal structure determination. PUBLIC HEALTH RELEVANCE: Crystallographic quality and quantity of ERAP1 C-dom, N-dom, and full-length protein obtained in this proposal will enable biochemical and structural studies of ERAP1 to enhance our understanding of the mechanisms of antigen processing. This information is necessary for the development of protective strategies for biodefense and is thus critical to public health.
描述(由申请方提供):抗原加工是涉及MHC限制和T细胞识别的细胞介导的免疫监视和应答的组成部分。加工的抗原肽,当通过MHC分子呈递到T细胞的细胞表面时,作为身份标签被我们的免疫系统监测。因此,抗原加工和呈递影响个体对感染性生物体的反应,并且已经涉及对疾病的易感性和自身免疫的发展。免疫系统消除病毒感染或恶性细胞的一种有效方法是产生导致靶细胞溶解的细胞毒性反应。这种抗病毒机制通常涉及MHC I类分子结合由感染细胞内合成的病毒蛋白质加工的肽,并将那些外源抗原肽呈递给细胞毒性T淋巴细胞(CTL),这可以消除病毒感染的自身细胞,从而消除新病毒产生的潜在来源。因此,了解抗原加工的机制对于对抗各种病原体至关重要。对于要被T细胞识别的表位,需要将外来抗原切割成具有适当大小的短肽,以便与MHC分子形成物理复合物。I类抗原肽的前体主要由胞浆中的蛋白酶体产生,然后通过与抗原加工相关的转运蛋白(TAP)转运到内质网(ER)的内腔中。最近,ER内的氨肽酶,命名为ERAP 1,已被确定为一个缺失的环节,修剪肽前体和产生的I类限制性表位的最终N-末端。我们最近成功表达和纯化活性ERAP 1,并在初步结晶筛选中获得其C-末端结构域(C-dom)的晶体,为这种关键酶提供了令人兴奋的高分辨率结构信息。在这个小型研究项目(R 03)的应用中,我们建议纯化ERAP 1 C-dom和复合物的晶体质量和数量,用于生物化学表征和高分辨率晶体结构测定。公共卫生关系:ERAP 1的C-dom,N-dom,和全长蛋白质的晶体质量和数量,在这个建议中获得将使ERAP 1的生化和结构研究,以提高我们对抗原加工机制的理解。这些信息对于制定生物防御的保护战略是必要的,因此对公共卫生至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hwai-Chen Guo其他文献

Hwai-Chen Guo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hwai-Chen Guo', 18)}}的其他基金

Structural and Bioinformatics Analyses of M1 Aminopeptidases
M1 氨基肽酶的结构和生物信息学分析
  • 批准号:
    10437967
  • 财政年份:
    2018
  • 资助金额:
    $ 8.13万
  • 项目类别:
Towards Structural Studies of Aminopeptidases in Antigen Processing
抗原加工中氨基肽酶的结构研究
  • 批准号:
    7877060
  • 财政年份:
    2009
  • 资助金额:
    $ 8.13万
  • 项目类别:
Towards Structural Studies of Aminopeptidases in Antigen Processing
抗原加工中氨基肽酶的结构研究
  • 批准号:
    8236091
  • 财政年份:
    2009
  • 资助金额:
    $ 8.13万
  • 项目类别:
Structure-Based Design of Small Molecules for Aspartylglucosaminuria
基于结构的天冬氨葡萄糖胺尿小分子设计
  • 批准号:
    8239512
  • 财政年份:
    2008
  • 资助金额:
    $ 8.13万
  • 项目类别:
Structural studies on an aminopeptidase inside the endoplasmic reticulum
内质网内氨肽酶的结构研究
  • 批准号:
    7643263
  • 财政年份:
    2008
  • 资助金额:
    $ 8.13万
  • 项目类别:
Structure-Based Design of Small Molecules for Aspartylglucosaminuria
基于结构的天冬氨葡萄糖胺尿小分子设计
  • 批准号:
    8012809
  • 财政年份:
    2008
  • 资助金额:
    $ 8.13万
  • 项目类别:
Structure-Based Design of Small Molecules for Aspartylglucosaminuria
基于结构的天冬氨葡萄糖胺尿小分子设计
  • 批准号:
    7341477
  • 财政年份:
    2008
  • 资助金额:
    $ 8.13万
  • 项目类别:
Structure-Based Design of Small Molecules for Aspartylglucosaminuria
基于结构的天冬氨葡萄糖胺尿小分子设计
  • 批准号:
    7554622
  • 财政年份:
    2008
  • 资助金额:
    $ 8.13万
  • 项目类别:
Crystallizing Hepatitis B Virus Reverse Transcriptase
结晶乙型肝炎病毒反转录酶
  • 批准号:
    6851919
  • 财政年份:
    2005
  • 资助金额:
    $ 8.13万
  • 项目类别:
Crystallizing Hepatitis B Virus Reverse Transcriptase
结晶乙型肝炎病毒反转录酶
  • 批准号:
    7033057
  • 财政年份:
    2005
  • 资助金额:
    $ 8.13万
  • 项目类别:

相似海外基金

RNA vaccine that exerts antitumor effect via non-canonical antigen presentation pathway
通过非经典抗原呈递途径发挥抗肿瘤作用的RNA疫苗
  • 批准号:
    19K07782
  • 财政年份:
    2019
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Climate change and fish disease: In vivo and in vitro studies of the modulation of the teleost antigen presentation pathway in response to thermal stress and viral infection using two different system
气候变化和鱼类疾病:使用两种不同的系统对硬骨鱼抗原呈递途径的调节响应热应激和病毒感染进行体内和体外研究
  • 批准号:
    469000-2014
  • 财政年份:
    2015
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Banting Postdoctoral Fellowships Tri-council
Climate change and fish disease: In vivo and in vitro studies of the modulation of the teleost antigen presentation pathway in response to thermal stress and viral infection using two different system
气候变化和鱼类疾病:使用两种不同的系统对硬骨鱼抗原呈递途径的调节响应热应激和病毒感染进行体内和体外研究
  • 批准号:
    469000-2014
  • 财政年份:
    2014
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Banting Postdoctoral Fellowships Tri-council
Herpes simplex virus-1 evasion of CD1d antigen presentation pathway
单纯疱疹病毒-1逃避CD1d抗原呈递途径
  • 批准号:
    8652945
  • 财政年份:
    2012
  • 资助金额:
    $ 8.13万
  • 项目类别:
Herpes simplex virus-1 evasion of CD1d antigen presentation pathway
单纯疱疹病毒-1逃避CD1d抗原呈递途径
  • 批准号:
    8466919
  • 财政年份:
    2012
  • 资助金额:
    $ 8.13万
  • 项目类别:
Herpes simplex virus-1 evasion of CD1d antigen presentation pathway
单纯疱疹病毒-1逃避CD1d抗原呈递途径
  • 批准号:
    9054767
  • 财政年份:
    2012
  • 资助金额:
    $ 8.13万
  • 项目类别:
Herpes simplex virus-1 evasion of CD1d antigen presentation pathway
单纯疱疹病毒-1逃避CD1d抗原呈递途径
  • 批准号:
    8373738
  • 财政年份:
    2012
  • 资助金额:
    $ 8.13万
  • 项目类别:
Investigation of the HLA class II Antigen Presentation Pathway in Estrogen Receptor Negative and Estrogen Receptor Positive Breast Carcinoma.
雌激素受体阴性和雌激素受体阳性乳腺癌中 HLA II 类抗原呈递途径的研究。
  • 批准号:
    186899
  • 财政年份:
    2009
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Fellowship Programs
Down regulation of antigen presentation pathway plays an important role in metastasis and progression of advanced stage of epithelial ovarian cancer.
抗原呈递途径的下调在上皮性卵巢癌晚期的转移和进展中发挥重要作用。
  • 批准号:
    21390449
  • 财政年份:
    2009
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
New anti-tuberculosis vaccine strategies by the use of the CD1-lipid antigen presentation pathway
利用 CD1-脂质抗原呈递途径的新抗结核疫苗策略
  • 批准号:
    15390317
  • 财政年份:
    2003
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了